Almirall, S.A. vs Bial
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
Market cap history
● Almirall, S.A.● Bial
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Almirall, S.A. ALM.MC | Bial |
|---|---|---|
| Profile | ||
| Country | 🇪🇸 Spain | 🇵🇹 Portugal |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | — |
| Founded | 1943 | 1924 |
| Size | ||
| Revenue | $1.2 B | — |
| Net income | $52 M | — |
| Employees | 1,773 | — |
| Profitability | ||
| Operating margin | 6.6% | — |
| Net margin | 4.2% | — |
| Return on equity | 3.2% | — |
| Growth | ||
| Revenue growth | 17.1% | — |
| Earnings per share growth | 358.4% | — |
| Cash | ||
| Free cash flow margin | 12.6% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Jan 2024; ratios FY2025 | Market cap — |